-
1
-
-
0029913746
-
Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical and epidemiological features
-
Bergogne-Berezin E, and Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996;9:148-65.
-
(1996)
Clin Microbiol Rev
, vol.9
, pp. 148-165
-
-
Bergogne-Berezin, E.1
Towner, K.J.2
-
2
-
-
56049089389
-
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
-
Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751-62.
-
(2008)
Lancet Infect Dis
, vol.8
, pp. 751-762
-
-
Karageorgopoulos, D.E.1
Falagas, M.E.2
-
3
-
-
62749144052
-
Management of meningitis due to antibiotic-resistant Acinetobacter species
-
Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, Paterson DL. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 2009;9:245-55.
-
(2009)
Lancet Infect Dis
, vol.9
, pp. 245-255
-
-
Kim, B.N.1
Peleg, A.Y.2
Lodise, T.P.3
Lipman, J.4
Li, J.5
Nation, R.6
Paterson, D.L.7
-
4
-
-
17644389620
-
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
-
Falagas ME, Kasiakou SKN. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005;40 1333-41.
-
(2005)
Clin Infect Dis
, vol.40
, pp. 1333-1341
-
-
Falagas, M.E.1
Kasiakou, S.K.N.2
-
5
-
-
33746616007
-
Tigecycline: A critical analysis
-
Stein GE, Craig W. Tigecycline: a critical analysis. Clin Infect Dis 2006;43:518-24.
-
(2006)
Clin Infect Dis
, vol.43
, pp. 518-524
-
-
Stein, G.E.1
Craig, W.2
-
6
-
-
33845370027
-
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
-
Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley J, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother 2006;58:1221-9.
-
(2006)
J Antimicrob Chemother
, vol.58
, pp. 1221-1229
-
-
Rodvold, K.A.1
Gotfried, M.H.2
Cwik, M.3
Korth-Bradley, J.4
Dukart, G.5
Ellis-Grosse, E.J.6
-
7
-
-
0036219620
-
Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis
-
Jiménez-Mejías ME, Pichardo-Guerrero C, Márquez-Rivas FJ, Martín-Lozano D, Prados T, Pachón J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002;21:212-4.
-
(2002)
Eur J Clin Microbiol Infect Dis
, vol.21
, pp. 212-214
-
-
Jiménez-Mejías, M.E.1
Pichardo-Guerrero, C.2
Márquez-Rivas, F.J.3
Martín-Lozano, D.4
Prados, T.5
Pachón, J.6
-
8
-
-
0032939527
-
Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
-
Levin AS, Barone AA, Penço J, Santos MV, Marinho IS, Arruda EA et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-11.
-
(1999)
Clin Infect Dis
, vol.28
, pp. 1008-1011
-
-
Levin, A.S.1
Barone, A.A.2
Penço, J.3
Santos, M.V.4
Marinho, I.S.5
Arruda, E.A.6
-
10
-
-
33845614387
-
Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: A systematic review of the available evidence
-
Falagas ME, Bliziotis IA, Tam VH. Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence. Int J Antimicrob Agents 2007;29:9-25.
-
(2007)
Int J Antimicrob Agents
, vol.29
, pp. 9-25
-
-
Falagas, M.E.1
Bliziotis, I.A.2
Tam, V.H.3
-
11
-
-
66149085768
-
Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis
-
Cunha BA. Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis. J Clin Microbiol 2009;47:1613.
-
(2009)
J Clin Microbiol
, vol.47
, pp. 1613
-
-
Cunha, B.A.1
-
12
-
-
70350638958
-
Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline
-
Wadi JA, Selawi F. Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline. Ann Saudi Med 2009;29:239-40.
-
(2009)
Ann Saudi Med
, vol.29
, pp. 239-240
-
-
Wadi, J.A.1
Selawi, F.2
-
13
-
-
39049122092
-
Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline
-
Wadi JA, Al Rub MA. Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline. Ann Saudi Med 2007;27:456-8.
-
(2007)
Ann Saudi Med
, vol.27
, pp. 456-458
-
-
Wadi, J.A.1
Al Rub, M.A.2
|